The FIGO Committee Report on the FIGO 2000 staging for gestational trophoblastic disease included criteria for the diagnosis of @entity1469 ( @entity1469 ). It recommended investigative tools for diagnosing @entity3 . Anatomical and prognostic indicators were combined into a stage : risk score to stratify @entity1 into low and high-risk groups. This is the first staging system to incorporate inclusive criteria that are likely to be adopted universally. The diagnostic evaluation of @entity1469 is presented. The rationale of using the various investigative tools is discussed. The problem of measuring @entity1 chorionic gonadotrophin (hCG) levels using commercial kits and the phenomenon of 'phantom hCG' is explored. The use of single agent chemotherapy for low-risk disease versus multi-agent chemotherapy for high-risk disease is discussed. Controversies regarding when to stop chemotherapy are explored with a view to minimizing the short and long-term @entity137 , in particular the small risk of developing a second @entity5 . Recommendations for the follow up of @entity1 after chemotherapy with particular reference to contraceptive advice and future pregnancies are discussed in the light of current evidence.

Diagnosis and management of XXXX .

@entity1 :: ('9606', 'Species') :: ['human', 'patients'] @entity137 :: ('MESH:D064420', 'Disease') :: ['toxicity'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignancy'] @entity1469 :: ('MESH:D031901', 'Disease') :: ['gestational trophoblastic neoplasia', 'GTN'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases']
@entity1469 :: (MESH:D031901,Disease) :: ['gestational trophoblastic neoplasia']
